Search results
Aug 25, 2016 · The wearable cardiac defibrillator (WCD) is a potential option for patients who are at significant risk for VT/VF but are not immediate candidates for ICD implantation. Recommendations for the WCD is largely based on data registries and smaller single or multicentre studies.
- Parikshit S. Sharma, Pierre Bordachar, Kenneth A. Ellenbogen
- 2016
Feb 19, 2013 · Since its introduction >3 decades ago, the implantable cardioverter-defibrillator (ICD) has been used extensively to enhance the survival of patients at high risk for sudden cardiac death resulting from life-threatening ventricular tachyarrhythmias (VTs; ie, sustained VT and ventricular fibrillation [VF]). 1, 2 Nevertheless, the invasive nature ...
- Arnon Adler, Amir Halkin, Sami Viskin
- 2013
For this meta-analysis, we identified research studies that (1) evaluated adult patients using WCDs; (2) provided data on one or more outcomes of interest (eg, all-cause and VT/VF-related mortality, VT/VF occurrence, appropriate and inappropriate shock therapy, and successful termination of VT/VF); and (3) were full-text studies published in the English language.
The AHA presented the WCD as a treatment option for VT and VF.7 Further, the WCD is seen as an option for primary prevention (in patients post-MI or post-explantation of an ICD when immediate reimplantation is not possible) and for secondary prevention (in patients with a history of SCA or sustained VT and VF, in whom ICD is ineffective ...
- Sabine Ettinger, Michal Stanak, Piotr Szymański, Claudia Wild, Romana Tandara Haček, Darija Erčević,...
- 10.2147/MDER.S144048
- 2017
- Med Devices (Auckl). 2017; 10: 257-271.
Jul 25, 2016 · Previous studies have established the safety and efficacy of the wearable cardioverter-defibrillator (WCD) as a noninvasive alternative for patients who are suspected of being at temporary risk for sudden cardiac death (SCD) caused by ventricular fibrillation (VF) or ventricular tachyarrhythmia (VT). 1,2 As demonstrated by large landmark trials, patients with ischemic cardiomyopathy (ICM) or ...
- Nadine K. Wäßnig, Michael Günther, Silvio Quick, Christian Pfluecke, Fabian Rottstädt, Steven J. Szy...
- 2016
Sep 8, 2023 · The observed increased risk of patients with prior ventricular arrhythmia for WCD and also later ICD shocks might support the novel IIa C recommendation for implantation of an ICD in patients with acute myocarditis and unstable VT or VF before hospital discharge proposed by the 2022 guidelines of the European Society of Cardiology, 4 as these patients bear a substantial risk for ventricular ...
People also ask
Are wearable cardiac defibrillators a viable option for VT/VF patients?
Are wearable cardioverter-defibrillators a viable prophylactic strategy for VT/VF patients?
Can implantable cardiac defibrillator prevent ventricular tachycardia and ventricular fibrillation?
Can wearable cardioverter defibrillator prevent sudden cardiac death?
How is a wearable defibrillator programmed?
May 1, 2019 · The LifeVest employs an advanced arrhythmia detection algorithm that uses heart rate, template matching, dual lead comparison, analog and digital signal filtering, rhythm stability analysis, and arrhythmia duration to guide therapy. 15 The treating physician can tailor the length of delay before shock and rate thresholds for VT/VF in individual ...
